Skip to main content
Skip to "About this site"

Table A.50.1

Warning View the most recent version.

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.

Table A.50.1
Number of bioproduct-related patents and pending patents, by geographical area and region, 2015
Table summary
This table displays the results of Number of bioproduct-related patents and pending patents. The information is grouped by Region (appearing as row headers), Establishments that hold a patent or have a pending patent, Existing patents and Pending patents, calculated using number units of measure (appearing as column headers).
Region	Establishments that hold a patent or have a pending patent	Existing patents	Pending patents
Region	number
Canada	62^{Table A.50.1 Note C}	1,822^{Note E: Use with caution}	167^{Table A.50.1 Note D}
Canada (Canadian Intellectual Property Office)	61^{Table A.50.1 Note C}	309^{Note E: Use with caution}	54^{Table A.50.1 Note D}
United States (U.S. Patent & Trademark Office)	57^{Table A.50.1 Note C}	379^{Note E: Use with caution}	45^{Table A.50.1 Note D}
Europe (European Patent Office)	41^{Table A.50.1 Note D}	309^{Note E: Use with caution}	38^{Table A.50.1 Note D}
Japan (Japan Patent Office)	21^{Table A.50.1 Note D}	36^{Note E: Use with caution}	14^{Note E: Use with caution}
Other geographical areas	26^{Table A.50.1 Note D}	789^{Note E: Use with caution}	17^{Note E: Use with caution}
Atlantic provinces	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	11^{Note E: Use with caution}	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Canada (Canadian Intellectual Property Office)	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	3^{Note E: Use with caution}	3^{Note E: Use with caution}
United States (U.S. Patent & Trademark Office)	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	4^{Note E: Use with caution}	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Europe (European Patent Office)	0	0	0
Japan (Japan Patent Office)	0	0	0
Other geographical areas	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	3^{Note E: Use with caution}	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Quebec	11^{Note E: Use with caution}	26^{Note E: Use with caution}	32^{Note E: Use with caution}
Canada (Canadian Intellectual Property Office)	11^{Note E: Use with caution}	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	9^{Note E: Use with caution}
United States (U.S. Patent & Trademark Office)	11^{Note E: Use with caution}	11^{Note E: Use with caution}	11^{Note E: Use with caution}
Europe (European Patent Office)	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Japan (Japan Patent Office)	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	0	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Other geographical areas	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Ontario	30^{Table A.50.1 Note D}	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	67^{Note E: Use with caution}
Canada (Canadian Intellectual Property Office)	30^{Table A.50.1 Note D}	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	21^{Note E: Use with caution}
United States (U.S. Patent & Trademark Office)	27^{Table A.50.1 Note D}	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	13^{Note E: Use with caution}
Europe (European Patent Office)	22^{Table A.50.1 Note D}	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	15^{Note E: Use with caution}
Japan (Japan Patent Office)	12^{Note E: Use with caution}	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Other geographical areas	16^{Note E: Use with caution}	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Prairies	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Canada (Canadian Intellectual Property Office)	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	0
United States (U.S. Patent & Trademark Office)	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Europe (European Patent Office)	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Japan (Japan Patent Office)	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Other geographical areas	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	0
British Columbia	13^{Table A.50.1 Note D}	48^{Table A.50.1 Note D}	49^{Note E: Use with caution}
Canada (Canadian Intellectual Property Office)	13^{Table A.50.1 Note D}	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	21^{Note E: Use with caution}
United States (U.S. Patent & Trademark Office)	10^{Note E: Use with caution}	21^{Table A.50.1 Note D}	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Europe (European Patent Office)	6^{Note E: Use with caution}	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	10^{Note E: Use with caution}
Japan (Japan Patent Office)	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	0	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
Other geographical areas	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	Note x: suppressed to meet the confidentiality requirements of the Statistics Act
x suppressed to meet the confidentiality requirements of the Statistics Act ^E use with caution Note: Coefficient of variation (CV) threshold Note C [ 0.100 < CV ≤ 0.150 ] Return to note C referrer Note D [ 0.150 < CV ≤ 0.250 ] Return to note D referrer Preliminary estimates, subject to change. Due to rounding, components may not add to totals. Coefficient of variation (CV) and standard error (SE) are used as quality indicators. Source: Statistics Canada, Bioproducts production and development survey 2015.

Date modified:: 2017-12-22